since 1944

In an interview with Arab Insights Care Magazine, our CEO, Mr. Sami Kiresepi, shared insights on  Santa Farma’s global vision, transformation strategy, and approach to leadership.

The "Pharmaceutical Manufacturing Technology" associate degree program within Kocaeli University Vocational School, to which we have provided academic and strategic support since its initial stages, was officially approved by YÖK and established!

Our Production Facility in GEBKİM Has Successfully Completed the Russian and Kazakhstan GMP Inspections!

Featured in the June issue of BusinessMED Magazine, our Corporate Communications team shared insights into our "Hidden Side of Your Heart" project, brought to life in collaboration with the Turkish Heart Foundation to deliver an "experience-driven" communication model combining technology and awareness.

In an exclusive interview with WORKSHOP Magazine, our R&D Director, Ersin YILDIRIM, shared Santa Farma's success achieved across 3 distinct categories in the "Türkiye's Patent Report 2025" evaluation, as well as our R&D investment priorities and future vision.

As Santa Farma, we are pleased to announce that we have submitted entries in two categories for the 2026 CPHI Pharma Awards.

We take pride in ranking among the top 500 once again this year in the "Türkiye's Top 500 Industrial Enterprises" research, prepared annually by the Istanbul Chamber of Industry (ISO).

Our Study on Türkiye's First Acemetacin Extended-Release Generic Product Featured in the 'European Journal of Applied Sciences'!

Conducted for the first time in our country in partnership with Forbes Türkiye and Statista, where companies cannot apply and results are shaped solely by independent employee feedback, the "Türkiye's Best Employers 2026" research has been concluded!

The in-vivo bioequivalence study led by our Clinical Trials Department for our product containing the active ingredient Phenyramidol HCl was featured in the "European Journal of Applied Sciences".